Decline of programmed death-1-positive circulating T regulatory cells predicts more favourable clinical outcome of patients with melanoma under immune checkpoint blockade.

Gambichler, T; Schröter, U; Höxtermann, S; Susok, L; Stockfleth, E; Becker, J C

Gambichler, T; Schröter, U; Höxtermann, S; Susok, L; Stockfleth, E; Becker, J C.

Afiliação

Gambichler T; Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Schröter U; Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Höxtermann S; Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Susok L; Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Stockfleth E; Skin Cancer Center, Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Becker JC; Translational Skin Cancer Research, DKTK Partner Site Essen/Düsseldorf, West German Cancer Center, Dermatology, University Duisburg-Essen, Essen, Germany.

Br J Dermatol ; 182(5): 1214-1220, 2020 05.

Article em En | MEDLINE | ID: mdl-31361026

Assuntos

Melanoma; Linfócitos T Reguladores; Humanos; Inibidores de Checkpoint Imunológico; Melanoma/tratamento farmacológico; Nivolumabe/uso terapêutico; Receptor de Morte Celular Programada 1

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_malignant_skin_melanoma Assunto principal: Linfócitos T Reguladores / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google